Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa

N Goldfarb^{1

2}, J R Ingram³, G B E Jemec^{4

5}, H B Naik⁶, V Piguet⁷, M J Hyde⁸, R Freese⁹, M A Lowes⁸, A Alavi⁷

Affiliations

¹ Departments of Medicine and Dermatology, University of Minnesota, Minneapolis, MN, U.S.A.
² Departments of Medicine and Dermatology, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, U.S.A.
³ Welsh Institute of Dermatology, University Hospital of Wales, Cardiff, U.K.
⁴ Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
⁵ Department of Dermatology, University of Copenhagen, Copenhagen, Denmark.
⁶ Department of Dermatology, University of California San Francisco, San Francisco, CA, U.S.A.
⁷ Department of Medicine, Division of Dermatology, Women's College Hospital, University of Toronto, Toronto, ON, Canada.
⁸ The Rockefeller University, New York, NY, U.S.A.
⁹ Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, U.S.A.

N Goldfarb et al. Br J Dermatol. 2020 Jan.

. 2020 Jan;182(1):240-242.

doi: 10.1111/bjd.18335. Epub 2019 Sep 17.

N Goldfarb^{1

2}, J R Ingram³, G B E Jemec^{4

5}, H B Naik⁶, V Piguet⁷, M J Hyde⁸, R Freese⁹, M A Lowes⁸, A Alavi⁷

¹ Departments of Medicine and Dermatology, University of Minnesota, Minneapolis, MN, U.S.A.
² Departments of Medicine and Dermatology, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, U.S.A.
³ Welsh Institute of Dermatology, University Hospital of Wales, Cardiff, U.K.
⁴ Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
⁵ Department of Dermatology, University of Copenhagen, Copenhagen, Denmark.
⁶ Department of Dermatology, University of California San Francisco, San Francisco, CA, U.S.A.
⁷ Department of Medicine, Division of Dermatology, Women's College Hospital, University of Toronto, Toronto, ON, Canada.
⁸ The Rockefeller University, New York, NY, U.S.A.
⁹ Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, U.S.A.

No abstract available

References

1. Kimball AB, Jemec GB, Yang M et al. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. Br J Dermatol 2014; 171:1434–42. - PubMed
1. Zouboulis CC, Tzellos T, Kyrgidis A et al. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol 2017; 177:1401–9. - PubMed
1. Hessam S, Scholl L, Sand M et al. A novel severity assessment scoring system for hidradenitis suppurativa. JAMA Dermatol 2018; 154:330–5. - PMC - PubMed
1. Thorlacius L, Garg A, Riis PT et al. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa. Br J Dermatol 2019; 181:483–91. - PubMed
1. Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016; 15:155–63. - PMC - PubMed